Small Molecule Inhibitor of ITK Disrupts TCR Signaling and Demonstrates Anti-Tumor Efficacy

被引：0

作者：

Faris, Mary ^{[1
]}

Malyankar, Uriel M. ^{[1
]}

Zeng, Qingping ^{[1
]}

Flynn, Gary A. ^{[2
]}

Fuer, Gerold ^{[3
]}

Kertesz, Nathalie L. ^{[1
]}

Vuga, Danka ^{[1
]}

Lee, Sandra ^{[4
]}

Rosario, Darlene ^{[1
]}

Bot, Adrian ^{[1
]}

机构：

[1] MannKind Corp, Valencia, CA USA

[2] Spacefill Enterprises LLC, Oro Valley, AZ USA

[3] SUNY Upstate Med Univ, Syracuse, NY USA

[4] Biogen Idec Inc, San Diego, CA USA

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1603 / 1604

页数：2

共 50 条

[31] How does TCR-T cell therapy exhibit a superior anti-tumor efficacy
Yang, Dandan
Duan, Zhihui
Yuan, Ping
Ding, Chengming
Dai, Xiaoming
Chen, Guodong
Wu, Daichao
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 687
[32] An orally bioavailable small molecule antagonist of TIM-3 signaling pathway shows potent anti-tumor activity
Sasikumar, Pottayil G.
Naremaddepalli, Sudarshan S.
Ramachandra, Raghuveer K.
Gowda, Nagesh
Devarapalli, Srinivaskumar
Adurthi, Sreenivas
Mani, Jiju
Nair, Rashmi
Dhudashiya, Amit A.
Samiulla, Dodheri S.
Gowda, Nagaraj M.
Ramachandra, Murali
CANCER RESEARCH, 2019, 79 (13)
[33] Basic approaches, challenges and opportunities for the discovery of small molecule anti-tumor drugs
Ma, Yu-Shui
Liu, Ji-Bin
Yang, Xiao-Li
Xin, Rui
Shi, Yi
Zhang, Dan-Dan
Wang, Hui-Min
Wang, Pei-Yao
Lin, Qin-Lu
Li, Wen
Fu, Da
AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 2386 - 2400
[34] MLN4924, a Novel Small Molecule Inhibitor of Nedd8-Activating Enzyme, Demonstrates Potent Anti-Tumor Activity in Diffuse Large B-Cell Lymphoma
Milhollen, Michael
Narayanan, Usha
Berger, Allison J.
Thomas, Michael
Traore, Tary
Yu, Jie
Zhang, Julie
Koenig, Erik
Garnsey, James J.
Langston, Steven P.
Soucy, Teresa A.
Smith, Peter G.
BLOOD, 2008, 112 (11) : 226 - 227
[35] The tankyrase inhibitor OM-153 demonstrates anti-tumor effect with a therapeutic index above 10
Brinch, Shoshy Alam
Amundsen-Isaksen, Enya
Espada, Sandra
Aizenshtadt, Aleksandra
Holmen, Lone
Hammarstrom, Clara
Hoyem, Merete
Scholz, Hanne
Grodeland, Gunnveig
Sowa, Sven T.
Galera-Prat, Albert
Lehtio, Lari
Meerts, Ilonka A. T. M.
Leenders, Ruben G. G.
Wegert, Anita
Krauss, Stefan
Waaler, Jo
CANCER RESEARCH, 2022, 82 (12)
[36] STC-15, a small molecule inhibitor of the RNA methyltransferase METTL3, activates anti-tumor immunity and reshapes the tumor microenvironment
Ofir-Rosenfeld, Yaara
Vasiliauskaite, Lina
Obacz, Joanna
Tsagkogeorga, Georgia
Holz, Josefin-Beate
McMahon, Jerry
Rausch, Oliver
MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
[37] Nuclear export inhibitor selinexor (KPT-330) demonstrates anti-tumor efficacy alone and in combination with chemotherapy in multiple breast cancer models
Arango, Natalia Paez
Evans, Kurt
Zhao, Ming
Yuca, Erkan
Scott, Stephen
Kim, Charissa
Naing, Aung
Meric-Bernstam, Funda
CANCER RESEARCH, 2016, 76
[38] The RAGE Inhibitor TTP488 (Azeliragon) Demonstrates Anti-Tumor Activity and Enhances the Efficacy of Radiation Therapy in Pancreatic Cancer Cell Lines
Alka, Kumari
Oyeniyi, Jacob F.
Mohammad, Ghulam
Zhao, Yi
Marcus, Stephen
Chinnaiyan, Prakash
CANCERS, 2025, 17 (01)
[39] CB-5083 is a novel first in class p97 inhibitor that disrupts cellular protein homeostasis and demonstrates anti-tumor activity in solid and hematological models
Moigne, Ronan L.
Wong, Steve
Soriano, Ferdie
Valle, Eduardo
Anderson, Daniel J.
Djakovic, Stevan
Menon, Mary-Kamala
Yao, Bing
Rice, Julie
Wang, Jinhai
Von Soly, Szerenke Kiss
Kumar, Brajesh
Chesi, Marta
Bergsagel, P. Leif
Zhou, Han-Jie
Wustrow, David
Rolfe, Mark
Yakes, F. Michael
CANCER RESEARCH, 2014, 74 (19)
[40] A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity
Shuwei Liang
Eric Tran
Xin Du
Jiajun Dong
Harrison Sudholz
Hao Chen
Zihan Qu
Nicholas D. Huntington
Jeffrey J. Babon
Nadia J. Kershaw
Zhong-Yin Zhang
Jonathan B. Baell
Florian Wiede
Tony Tiganis
Nature Communications, 14

← 1 2 3 4 5 →